Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 472 (RNA5SP472) is classified as a processed pseudogene, a genomic element that resembles the 5S rRNA gene but is non-functional due to mutations or lack of regulatory elements[1][4]. Pseudogenes like RNA5SP472 are typically non-coding and do not produce proteins. While some pseudogenes can affect the expression of related genes through noncoding RNA mechanisms, such as acting as microRNA decoys or generating regulatory small RNAs[6], there is no evidence that RNA5SP472 has any established functional, pathological, or therapeutic significance. It is not considered a drug target, receptor, enzyme, or transporter. Some studies have investigated the potential regulatory or biomarker roles of pseudogenes in cancer, but RNA5SP472 is not specifically implicated[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 472 (RNA5SP472).